Sugi Predict

Sugi Predict / Compounds / SCHEMBL14768607

SCHEMBL14768607

SCHEMBL14768607

Cc1cc(Cl)cc(Sc2ccc(C#N)cc2CN2CCCCC2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRNA7 P36544 1/20 0.39
▸ CACNB4 O00305 4/20 0.38
▸ CACNA1A O00555 4/20 0.38
▸ CACNA1G O43497 4/20 0.38
▸ CACNG3 O60359 4/20 0.38
▸ CACNA1F O60840 4/20 0.38
▸ CACNA1H O95180 4/20 0.38
▸ CACNB3 P54284 4/20 0.38
▸ CACNA2D1 P54289 4/20 0.38
▸ CACNG7 P62955 4/20 0.38
▸ CACNA1B Q00975 4/20 0.38
▸ CACNA1D Q01668 4/20 0.38
▸ CACNB1 Q02641 4/20 0.38
▸ CACNG1 Q06432 4/20 0.38
▸ CACNB2 Q08289 4/20 0.38
▸ CACNA1S Q13698 4/20 0.38
▸ CACNA1C Q13936 4/20 0.38
▸ CACNA1E Q15878 4/20 0.38
▸ CACNA2D4 Q7Z3S7 4/20 0.38
▸ CACNA2D3 Q8IZS8 4/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14768619 0.92 CHRNA7 (0.43) CHRNA7CACNB4CACNA1ACACNA1GCACNG3
SCHEMBL14768596 0.89 L3MBTL1 (0.38) DRD2DRD4DRD3L3MBTL1HTR1A
SCHEMBL14768623 0.89 CYP2A13 (0.40) DRD2DRD4DRD3L3MBTL1MAPK1
SCHEMBL14768585 0.89 KDM1A (0.38) DRD2DRD4DRD3HRH3HTR1A
SCHEMBL14768591 0.89 ACHE (0.38) DRD2DRD4DRD3NPSR1HRH3
SCHEMBL14768622 0.88 KMT2A (0.40) CHRNA7DRD2DRD4DRD3HTR1A
SCHEMBL14768595 0.84 MEN1 (0.35) DRD2DRD4DRD3HRH3HTR1A
SCHEMBL14039266 0.84 MLNR (0.39) DRD2DRD4DRD3HTR1AHTR3A
SCHEMBL14039315 0.83 DRD4 (0.34) CACNA2D1DRD2DRD4DRD3HTR1A
SCHEMBL14039313 0.83 SLC6A4 (0.40) DRD2DRD4DRD3HRH3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160031841-A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS AXIKIN PHARMACEUTICALS, INC. 2016-02-04 — — US disclosed
US-9187425-B2 2,5-disubstituted arylsulfonamide CCR3 antagonists AXIKIN PHARMACEUTICALS, INC. (US) 2015-11-17 — — US disclosed
US-20140066446-A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS AXIKIN PHARMACEUTICALS, INC. (US) 2014-03-06 — — US disclosed
US-8563544-B2 2,5-disubstituted arylsulfonamide CCR3 antagonists AXIKIN PHARMACEUTICALS, INC. (US) 2013-10-22 — — US disclosed
US-20130065889-A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS AXIKIN PHARMACEUTICALS, INC. (US) 2013-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031841-A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS CCR3, CCR1, CCR4 CHRNA7 947/4885CACNB4 2668/4885CACNA1A 2141/4885
US-20140066446-A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS CCR3, CCR1, CCR4 CHRNA7 947/4885CACNB4 2668/4885CACNA1A 2141/4885
US-20130065889-A1 2,5-DISUBSTITUTED ARYLSULFONAMIDE CCR3 ANTAGONISTS CCR3, CCR1, CCR4 CHRNA7 947/4885CACNB4 2668/4885CACNA1A 2141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.